Testosterone for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 18 Aug 2021: Trial registered, NCT05011383
  2. 31 Aug 2021: Trial started, NCT05011383

The trials

NCT05011383: High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers

State
Under way
Phase
Phase 2
People
51 planned
Started
31 Aug 2021
Primary completion
3 Aug 2027
Arms
ATM, CDK12, CHEK2
Results
None posted
  1. 18 Aug 2021: Trial registered
  2. 31 Aug 2021: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Androderm, Androgel, Android-t, Androlan, High dose testosterone, Intrinsa, Jatenzo Pill, Livensa, Natesto, Subcutaneous Testosterone Implants, Vogelxo, topical testosterone.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.